MedTrace Logo

Bladder Complaints in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical Stimulation

NCT05814614 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-03-28

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effect of pelvic physical therapy with different types of electrical stimulation(ES) for bladder complaints in people with Parkinson's disease.

The main question it aims to answer is:

What is the effect of pelvic physical therapy with ES for bladder complaints in people with Parkinson's disease.

Secondary question:

What is the most effective type of ES on bladder complaints in people with Parkinson's disease.

Participants will be randomized into three groups. Two different kinds of ES and a sham group. Participants will receive eight session of pelvic physical therapy. Pelvic physical therapy consists of e.g. bladder training, pelvic floor muscle exercises and biofeedback.

Conditions

  • Lower Urinary Tract Symptoms
  • Parkinson Disease

Interventions

OTHER

pelvic physical therapy

Pelvic floor muscle exercises, biofeedback, bladder training

Sponsors & Collaborators

  • Royal Dutch Society for Physical Therapy

    collaborator UNKNOWN

  • The Dutch Brain Foundation

    collaborator OTHER

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • Rob Pelger, Prof. · Head department urology Leiden University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-25
Primary Completion
2025-03-01
Completion
2026-05-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05814614 on ClinicalTrials.gov